Melanoma and Skin Cancer Trials Limited

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Sirolimus Topical Cream · Oncology
Sirolimus is an mTOR inhibitor that suppresses immune cell proliferation and angiogenesis when applied topically to skin lesions.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Melanoma and Skin Cancer Trials Limited portfolio CI brief
Melanoma and Skin Cancer Trials Limited pipeline updates RSS